Nature Biotechnology 2006 Mark Ratner - Abstracts
| Nature Biotechnology 2006 Mark Ratner | |||||
| Title | Subject | Authors | |||
|---|---|---|---|---|---|
| A turbulent year at the agency.(increase in drug approval Food and Drug Administration) | Business | Mark Ratner | |||
| Complement inhibitor finally find orphan niches. | Business | Mark Ratner | |||
| Daphne Zohar.(PureTech Ventures) | Business | Mark Ratner | |||
| Einer Elhauge.(biotechnology is an essential part of health law) | Business | Mark Ratner | |||
| Looking for solid ground along the critical path. | Business | Mark Ratner | |||
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.